These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 30684524)
1. A three plasma microRNA signature for papillary thyroid carcinoma diagnosis in Chinese patients. Wang Z; Lv J; Zou X; Huang Z; Zhang H; Liu Q; Jiang L; Zhou X; Zhu W Gene; 2019 Apr; 693():37-45. PubMed ID: 30684524 [TBL] [Abstract][Full Text] [Related]
2. A three-microRNA panel in serum as novel biomarker for papillary thyroid carcinoma diagnosis. Zou X; Gao F; Wang ZY; Zhang H; Liu QX; Jiang L; Zhou X; Zhu W Chin Med J (Engl); 2020 Nov; 133(21):2543-2551. PubMed ID: 33009019 [TBL] [Abstract][Full Text] [Related]
3. Exosomal miRNAs are potential diagnostic biomarkers between malignant and benign thyroid nodules based on next-generation sequencing. Pan Q; Zhao J; Li M; Liu X; Xu Y; Li W; Wu S; Su Z Carcinogenesis; 2020 Mar; 41(1):18-24. PubMed ID: 31560760 [TBL] [Abstract][Full Text] [Related]
4. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis. Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288 [TBL] [Abstract][Full Text] [Related]
5. Identification of exosomal miRNA biomarkers for diagnosis of papillary thyroid cancer by small RNA sequencing. Dai D; Tan Y; Guo L; Tang A; Zhao Y Eur J Endocrinol; 2020 Jan; 182(1):111-121. PubMed ID: 31721725 [TBL] [Abstract][Full Text] [Related]
6. A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis. Zhou X; Wen W; Shan X; Zhu W; Xu J; Guo R; Cheng W; Wang F; Qi LW; Chen Y; Huang Z; Wang T; Zhu D; Liu P; Shu Y Oncotarget; 2017 Jan; 8(4):6513-6525. PubMed ID: 28036284 [TBL] [Abstract][Full Text] [Related]
7. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection. Zhang H; Zou X; Wu L; Zhang S; Wang T; Liu P; Zhu W; Zhu J Cancer Med; 2020 Feb; 9(3):1230-1241. PubMed ID: 31856390 [TBL] [Abstract][Full Text] [Related]
8. Altered Serum MicroRNA Profile May Serve as an Auxiliary Tool for Discriminating Aggressive Thyroid Carcinoma from Nonaggressive Thyroid Cancer and Benign Thyroid Nodules. Zhang A; Wang C; Lu H; Chen X; Ba Y; Zhang C; Zhang CY Dis Markers; 2019; 2019():3717683. PubMed ID: 31636734 [TBL] [Abstract][Full Text] [Related]
9. Plasma-Derived miRNA-222 as a Candidate Marker for Papillary Thyroid Cancer. Kondrotienė A; Daukša A; Pamedytytė D; Kazokaitė M; Žvirblienė A; Daukšienė D; Simanavičienė V; Klimaitė R; Golubickaitė I; Stakaitis R; Šarauskas V; Verkauskienė R; Žilaitienė B Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899424 [TBL] [Abstract][Full Text] [Related]
10. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis. Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239 [TBL] [Abstract][Full Text] [Related]
11. Circulating microRNA124-3p, microRNA9-3p and microRNA196b-5p may be potential signatures for differential diagnosis of thyroid nodules. Yu S; Liu X; Zhang Y; Li J; Chen S; Zheng H; Reng R; Zhang C; Chen J; Chen L Oncotarget; 2016 Dec; 7(51):84165-84177. PubMed ID: 27705935 [TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of five miRNAs in papillary thyroid carcinomas. Qiao DH; He XM; Deng X; Ji YC; Yang H; Cheng L; Zhou XY J Clin Lab Anal; 2021 Sep; 35(9):e23907. PubMed ID: 34268792 [TBL] [Abstract][Full Text] [Related]
13. A novel serum microRNA signature to screen esophageal squamous cell carcinoma. Huang Z; Zhang L; Zhu D; Shan X; Zhou X; Qi LW; Wu L; Zhu J; Cheng W; Zhang H; Chen Y; Zhu W; Wang T; Liu P Cancer Med; 2017 Jan; 6(1):109-119. PubMed ID: 28035762 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA expression profiling analysis in serum for nasopharyngeal carcinoma diagnosis. Zou X; Zhu D; Zhang H; Zhang S; Zhou X; He X; Zhu J; Zhu W Gene; 2020 Feb; 727():144243. PubMed ID: 31743768 [TBL] [Abstract][Full Text] [Related]
17. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis. Zou X; Wei J; Huang Z; Zhou X; Lu Z; Zhu W; Miao Y Cancer Med; 2019 Jun; 8(6):2810-2822. PubMed ID: 31006985 [TBL] [Abstract][Full Text] [Related]
18. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer. Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526 [TBL] [Abstract][Full Text] [Related]
19. Identification of four plasma microRNAs as potential biomarkers in the diagnosis of male lung squamous cell carcinoma patients in China. Shan X; Zhang H; Zhang L; Zhou X; Wang T; Zhang J; Shu Y; Zhu W; Wen W; Liu P Cancer Med; 2018 Jun; 7(6):2370-2381. PubMed ID: 29673101 [TBL] [Abstract][Full Text] [Related]
20. A panel of microRNA signature in serum for colorectal cancer diagnosis. Zhu M; Huang Z; Zhu D; Zhou X; Shan X; Qi LW; Wu L; Cheng W; Zhu J; Zhang L; Zhang H; Chen Y; Zhu W; Wang T; Liu P Oncotarget; 2017 Mar; 8(10):17081-17091. PubMed ID: 28177881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]